Search results
Results from the WOW.Com Content Network
After sustaining an uptrend on the markets since bottoming in February, GlaxoSmithKline (NYSE:GSK) still has an attractive profile for income and value investors. The stock’s rock-solid dividend ...
SCHD Dividend Yield data by YCharts. However, don't make the mistake of thinking that Schwab U.S. Dividend Equity ETF is only for ETF investors. You can use this as a foundation on which to build ...
The stagnating price paired with dividend raises and the prospect of earnings growth has pushed the share's dividend yield up to 3% and the forward price-to-earnings ratio (P/E) down to just 21.5 ...
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3] [4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
In the latest trading session, GlaxoSmithKline (GSK) closed at $41.54, marking a +1.47% move from the previous day.
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [ 4 ] [ 5 ] The company's product portfolio includes prescription medicines and vaccines .
For premium support please call: 800-290-4726 more ways to reach us